Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.43 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.39 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.36 |
| ▸ | TACR2 | P21452 | 2/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3651402 | 0.77 | MAPT (0.61) | RPS6KA3NPC1MAPTRAB9APLA2G4A | |
| SCHEMBL1764460 | 0.76 | MAPT (0.60) | RPS6KA3NPC1MAPTRAB9APLA2G4A | |
| SCHEMBL6037370 | 0.71 | POLB (0.50) | RPS6KA3MAPTPTPN2PTPN1POLB | |
| SCHEMBL24503911 | 0.69 | NPC1 (0.48) | ASAH1NPC1MAPTRAB9APTPN2 | |
| SCHEMBL16398499 | 0.68 | GRM2 (0.75) | RPS6KA3NPC1MAPTRAB9ATDP1 | |
| SCHEMBL3415845 | 0.68 | ESR1 (0.36) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL9091544 | 0.66 | POLB (0.55) | MAPTRAB9APOLBMAPK1ATM | |
| SCHEMBL31066856 | 0.66 | SLC9A1 (0.55) | ASAH1MAPTPLA2G4APOLBMAPK1 | |
| SCHEMBL25613143 | 0.66 | SLC9A1 (0.55) | ASAH1MAPTPLA2G4APOLBMAPK1 | |
| SCHEMBL27542130 | 0.66 | ESR1 (0.46) | NPC1MAPTRAB9ATRPV1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2942047-B1 | Cosmetic product | BEIERSDORF AG (DE) | 2020-09-02 | — | — | EP | disclosed |
| EP-2942045-B1 | Bead-shaped cosmetic dosage forms | BEIERSDORF AG (DE) | 2018-10-10 | — | — | EP | disclosed |
| EP-2942046-B1 | Compositions having an outer gel phase and an inner particulate phase, containing stabilised oxidation and/or UV-sensitive active agents | BEIERSDORF AG (DE) | 2018-07-11 | — | — | EP | disclosed |
| EP-3139897-A1 | PREPARATIONS HAVING AN OUTER GEL PHASE AND AN INNER PARTICULATE PHASE COMPRISING STABILIZED OXIDATION-AND/OR UV-SENSITIVE ACTIVE INGREDIENTS | Beiersdorf AG (DE) | 2017-03-15 | — | — | EP | disclosed |
| EP-3139893-A1 | COSMETIC PRODUCT | Beiersdorf AG (DE) | 2017-03-15 | — | — | EP | disclosed |
| EP-3139896-A1 | BEAD-SHAPED COSMETIC DOSAGE FORMS | Beiersdorf AG (DE) | 2017-03-15 | — | — | EP | disclosed |
| US-20170050054-A1 | COSMETIC PRODUCT | BEIERSDORF AG (DE) | 2017-02-23 | — | — | US | disclosed |
| WO-2015169456-A1 | COSMETIC PRODUCT | BEIERSDORF AG (DE) | 2015-11-12 | — | — | WO | disclosed |
| WO-2015169455-A1 | PREPARATIONS HAVING AN OUTER GEL PHASE AND AN INNER PARTICULATE PHASE COMPRISING STABILIZED OXIDATION-AND/OR UV-SENSITIVE ACTIVE INGREDIENTS | BEIERSDORF AG (DE) | 2015-11-12 | — | — | WO | disclosed |
| WO-2015169454-A1 | BEAD-SHAPED COSMETIC DOSAGE FORMS | BEIERSDORF AG (DE) | 2015-11-12 | — | — | WO | disclosed |
| EP-1423083-A1 | STABILISATION OF OXIDATION-SENSITIVE AND UV-SENSITIVE ACTIVE INGREDIENTS | Beiersdorf AG (DE) | 2004-06-02 | — | — | EP | disclosed |
| EP-1423088-A2 | STABILISATION OF OXIDATION-SENSITIVE AND UV-SENSITIVE ACTIVE INGREDIENTS | Beiersdorf AG (DE) | 2004-06-02 | — | — | EP | disclosed |
| EP-1423087-A1 | STABILISATION OF OXIDATION-SENSITIVE AND/OR UV-SENSITIVE ACTIVE INGREDIENTS | Beiersdorf AG (DE) | 2004-06-02 | — | — | EP | disclosed |
| WO-2003039506-A2 | COSMETIC AND DERMATOLOGICAL LIGHT PROTECTION FORMULATIONS WITH A CONTENT OF HYDROXYBENZOPHENONES AND ALKYLNAPHTHALATES | BEIERSDORF AG (DE) | 2003-05-15 | — | — | WO | disclosed |
| WO-2003020234-A1 | STABILISATION OF OXIDATION-SENSITIVE AND/OR UV-SENSITIVE ACTIVE INGREDIENTS | BEIERSDORF AG (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020232-A2 | STABILISATION OF COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING REPELLENT ACTIVE INGREDIENTS | BEIERSDORF AG (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020233-A2 | STABILISATION OF UV-SENSITIVE ACTIVE INGREDIENTS | BEIERSDORF AG (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020317-A2 | COSMETIC AND DERMATOLOGICAL LIGHT-PROTECTIVE FORMULATION WITH A CONTENT OF WATER-SOLUBLE UV-FILTER SUBSTANCES AND ALKYLNAPHTHALATES | BEIERSDORF AG (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020235-A2 | STABILISATION OF OXIDATION-SENSITIVE AND UV-SENSITIVE ACTIVE INGREDIENTS | BEIERSDORF AG (DE) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020224-A1 | STABILISATION OF OXIDATION-SENSITIVE AND UV-SENSITIVE ACTIVE INGREDIENTS | BEIERSDORF AG (DE) | 2003-03-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170050054-A1 | COSMETIC PRODUCT | POLR1C, CUTA, TNF | RPS6KA3 3043/4885ASAH1 1466/4885NPC1 3339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.